Our Members

As a member-focused Association, our members are at the heart of everything we do at the PRI.

In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.

Find out more about the different ways you and your organization can get involved with the PRI’s activities.

  • Microbiome Regulatory Science Support Work
  • Pre-competitive Task Groups
  • Year-round networking and project-related communication support

More than 100 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.

NeoBioSys

NeoBioSys

NeoBioSys is specialized in fermentation processes. We offer R&D and process intensification for the production of microorganisms and metabolites and production up to industrial scale.

 

Nestlé Health Science

Nestlé Health Science

Laurent Ameye

Global Regulatory Compliance Manager

Our expertise areas includes food supplements, medical nutrition, and pharmaceutical solutions on areas including food allergies, metabolic/gastrointestinal health, healthy aging and adult acute care.

 

Nexbiome Therapeutics

Nexbiome Therapeutics

Stanislas DESJONQUERES

CEO

We turn into products academic therapeutic and microbiome-based projects in Human. Our value is to source, fund and operate such projects.

 

NIZO

NIZO

Ioana Iorga

Business Development Manager

We support the discovery, development, up-scaling and (pilot) production of microbiome-based products, including dietary supplements (pro-/post- and synbiotics) and LBPs.

 

Orion Corporation Orion Pharma R&D

Orion Corporation Orion Pharma R&D

Mirja Huhtinen

Director, Animal Health R&D

Orion Pharma Animal Health R&D develops innovative medicinal, ProHealth and microbiome products to global markets. Our flagship microbiome product is Broilact.

 

PharmaBiome AG

PharmaBiome AG

Tomas de Wouters

Co-Founder & CEO

Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.

 

PHYLOGENE

PHYLOGENE

Gilbert Skorski

CEO

Multi-omics CRO

 

PiLeje

PiLeje

Pascaline Gervoson

CEO

PiLeJe’s purpose is to promote the health of each individual and maintain it for as long as possible. This is achieved by applying what Dr Christian Leclerc, the Group’s founder, calls “health-based medicine”.